Table 2.
Gene | Node degree | Crude HR (95% CI)* | Crude P | Coefficient β** |
---|---|---|---|---|
NIP7 | 24 | 0.509 (0.281–0.920) | 0.025 | −0.676 |
RPS3 | 24 | 1.296 (0.734–2.290) | 0.371 | 0.260 |
MRPL3 | 22 | 1.230 (0.696–2.173) | 0.477 | 0.207 |
RPL10L | 22 | 0.495 (0.272–0.900) | 0.021 | −0.703 |
RPL23A | 22 | 0.708 (0.401–1.251) | 0.235 | −0.345 |
RPS23 | 19 | 0.566 (0.314–1.019) | 0.058 | −0.569 |
RPS3A | 19 | 0.823 (0.465–1.455) | 0.502 | −0.195 |
MCM2 | 18 | 2.383 (1.292–4.393) | 0.005 | 0.868 |
RPL36 | 18 | 0.752 (0.423–1.336) | 0.331 | −0.285 |
WDR12 | 18 | 1.658 (0.929–2.960) | 0.087 | 0.506 |
The GSE30929 do not have the MKI67IP expression data;
low gene expression was the reference group;
derived from the univariate Cox proportional hazards regression analysis in PDAC patients.
DRFS – distant recurrence-free survival.